Furthermore the treatment both before and after early seizures with mTOR inhibitors was able to decrease both seizure susceptibility and later autistic-like behaviours [22], thus supporting the hypothesis that mTOR inhibitors could be useful for the pharmacological treatment of TSC associated autism spectrum disorders. This evidence concerns the gene MTOR and tuberous sclerosis.